Brief: Pasithea Therapeutics Corp And Evotec SE Enter Into Drug Development Agreement
11/10/2021 13:09
Oct 11 (Reuters) - Evotec SE EVTG.DE :
* PASITHEA THERAPEUTICS CORP. AND EVOTEC SE ENTER INTO DRUG
DEVELOPMENT AGREEMENT
* PASITHEA THERAPEUTICS - ANNOUNCED INITIATION OF NEW
CHEMICAL
ENTITY DEVELOPMENT PROGRAM, NAMED EVOTEC AS NCE RESEARCH PARTNER
Source text for Eikon: ID:nGNX4gyJYs
Further company coverage: EVTG.DE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement